Cannabis Study on Veterans with PTSD

Photo via Flickr user Paul Sableman

By Joan Eberhardt


DEA Approved a Study on Cannabis and Veterans with PTSD

The U.S. Drug Enforcement Administration (DEA) has authorized a study on the effects cannabis has on veterans experiencing Post Traumatic Stress Disorder (PTSD). This study is the first of its kind authorized by a government regulating agency, and it will test the efficacy and safety of botanical marijuana on 76 U.S. Military veterans.

Anecdotally, veterans organizations, such as Veterans for Medical Cannabis Access, say cannabis has medical benefits that could mitigate the effects of PTSD and reduce opioid use among those suffering from PTSD. The Multidisciplinary Association for Psychedelic Studies will lead this $2.1 million, placebo-controlled study, which is being funded by the Colorado Department of Health and Environment.

The authors of the study hope it will provide “vital information on marijuana dosing, composition, side effects, and areas of benefit to clinicians and legislators considering marijuana as a treatment for PTSD.”


Legal Marijuana Needs Rebranding

Branding used by the legal marijuana industry pretty quickly became a cliche.

James I. Bowie, a sociologist who examines logos and patterns in marketing, wrote at Slate last week that the legal cannabis market overwhelmingly uses similar imagery, colors and designs in its advertising, and argues that when everyone looks the same no one can stand out.

“Everything is named ‘canna-something’ or ‘mari-something,’ with a green and black logo and pot leaves,” a backer of Marley Natural said. Marley Natural had recently used a green leaf as a secondary element of its logo, before dropping them recently to focus on its lion emblem.


Medical Board Blasts Governor in Illinois

Illinoisans have a contentious relationship with their governor. Bruce Rauner is only one year into the four year term, and because the state has operated for nearly a full year without a budget, social service organizations and universities are suffering.

While Rauner has not prevented the state’s Medical Marijuana Pilot Program from moving forward, he has repeatedly vetoed measures that would expand the program and allow it to reach a greater number of patients. The Medical Cannabis Advisory Board has recommended on several occasions that qualifying medical conditions be added to the program and every time Rauner has vetoed those recommendations.

“We don’t get everything that we want on this board anyway, several times over,” board chair Dr. Leslie Mendoza Temple told the Chicago Tribune.

At a hearing this week, the Board approved adding 10 new conditions to the program, including Type 1 Diabetes and certain panic disorders, and sent their recommendations to Rauner to approve or, if history is any indication, deny.

Quick Puffs


Leave a Reply